| First Author | Kajimura D | Year | 2014 |
| Journal | Mol Metab | Volume | 3 |
| Issue | 7 | Pages | 770-7 |
| PubMed ID | 25353004 | Mgi Jnum | J:223092 |
| Mgi Id | MGI:5647952 | Doi | 10.1016/j.molmet.2014.07.006 |
| Citation | Kajimura D, et al. (2014) Foxo1 regulates Dbh expression and the activity of the sympathetic nervous system in vivo. Mol Metab 3(7):770-7 |
| abstractText | The transcription factor FoxO1 regulates multiple physiological processes. Here, we show that FoxO1 is highly expressed in neurons of the locus coeruleus and of various sympathetic ganglions, but not in the adrenal medulla. Consistent with this pattern of expression, mice lacking FoxO1 only in sympathetic neurons (FoxO1 Dbh-/-) display a low sympathetic tone without modification of the catecholamine content in the adrenal medulla. As a result, FoxO1 Dbh-/- mice demonstrate an increased insulin secretion, improved glucose tolerance, low energy expenditure, and high bone mass. FoxO1 favors catecholamine synthesis because it is a potent regulator of the expression of Dbh that encodes the initial and rate-limiting enzyme in the synthesis of these neurotransmitters. By identifying FoxO1 as a transcriptional regulator of the sympathetic tone, these results advance our understanding of the control of some aspects of metabolism and of bone mass accrual. |
